New insights into the regulation of protein kinase C and novel phorbol ester receptors
- PMID: 10506570
New insights into the regulation of protein kinase C and novel phorbol ester receptors
Abstract
Protein kinase C (PKC), a family of related serine-threonine kinases, is a key player in the cellular responses mediated by the second messenger diacylglycerol (DAG) and the phorbol ester tumor promoters. The traditional view of PKCs as DAG/phospholipid-regulated proteins has expanded in the last few years by three seminal discoveries. First, PKC activity and maturation is controlled by autophosphorylation and transphosphorylation mechanisms, which includes phosphorylation of PKC isozymes by phosphoinositide-dependent protein kinases (PDKs) and tyrosine kinases. Second, PKC activity and localization are regulated by direct interaction with different types of interacting proteins. Protein-protein interactions are now recognized as important mechanisms that target individual PKCs to different intracellular compartments and confer selectivity by associating individual isozymes with specific substrates. Last, the discovery of novel phorbol ester receptors lacking kinase activity allows us to speculate that some of the biological responses elicited by phorbol esters or by activation of receptors coupled to elevation in DAG levels could be mediated by PKC-independent pathways.
Similar articles
-
Pharmacology of the receptors for the phorbol ester tumor promoters: multiple receptors with different biochemical properties.Biochem Pharmacol. 2000 Nov 15;60(10):1417-24. doi: 10.1016/s0006-2952(00)00470-6. Biochem Pharmacol. 2000. PMID: 11020443
-
Novel "nonkinase" phorbol ester receptors: the C1 domain connection.Mol Pharmacol. 2002 Apr;61(4):759-67. doi: 10.1124/mol.61.4.759. Mol Pharmacol. 2002. PMID: 11901214 Review.
-
Protein kinase C isoenzymes display differential affinity for phorbol esters. Analysis of phorbol ester receptors in B cell differentiation.J Immunol. 1992 Oct 15;149(8):2560-8. J Immunol. 1992. PMID: 1401894
-
Targeting protein kinase C and "non-kinase" phorbol ester receptors: emerging concepts and therapeutic implications.Biochim Biophys Acta. 2005 Dec 30;1754(1-2):296-304. doi: 10.1016/j.bbapap.2005.07.034. Epub 2005 Sep 12. Biochim Biophys Acta. 2005. PMID: 16202672
-
Protein kinase C and other diacylglycerol effectors in cancer.Nat Rev Cancer. 2007 Apr;7(4):281-94. doi: 10.1038/nrc2110. Nat Rev Cancer. 2007. PMID: 17384583 Review.
Cited by
-
Coincident elevation of cAMP and calcium influx by PACAP-27 synergistically regulates vasoactive intestinal polypeptide gene transcription through a novel PKA-independent signaling pathway.J Neurosci. 2002 Jul 1;22(13):5310-20. doi: 10.1523/JNEUROSCI.22-13-05310.2002. J Neurosci. 2002. PMID: 12097482 Free PMC article.
-
Emerging and diverse roles of protein kinase C in immune cell signalling.Biochem J. 2003 Dec 15;376(Pt 3):545-52. doi: 10.1042/BJ20031406. Biochem J. 2003. PMID: 14570590 Free PMC article. Review.
-
Investigation of the inhibitory effects of HA-1077 and Y-32885 on the translocation of PKCbetaI, PKCbetaII and PKCzeta in human neutrophils.Mediators Inflamm. 2001 Dec;10(6):315-21. doi: 10.1080/09629350120102334. Mediators Inflamm. 2001. PMID: 11817672 Free PMC article.
-
Protein kinases C isozymes are differentially expressed in human breast carcinomas.Life Sci. 2009 May 22;84(21-22):766-71. doi: 10.1016/j.lfs.2009.03.007. Epub 2009 Mar 24. Life Sci. 2009. PMID: 19324060 Free PMC article.
-
Evolving mechanisms of vascular smooth muscle contraction highlight key targets in vascular disease.Biochem Pharmacol. 2018 Jul;153:91-122. doi: 10.1016/j.bcp.2018.02.012. Epub 2018 Feb 13. Biochem Pharmacol. 2018. PMID: 29452094 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources